2020
DOI: 10.1007/s00204-020-02753-y
|View full text |Cite
|
Sign up to set email alerts
|

The role of hepatic cytochrome P450s in the cytotoxicity of sertraline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 55 publications
1
9
0
Order By: Relevance
“…For both HepG2 and Caco2, an approximately 20% decrease in cell survival after a 24 h incubation period is observed for an initial SER concentration of 6.25 µM. This agrees with data obtained previously for HepG2 cells treated with SER [48]. It was found that for SER concentrations above 12.5 µM, which corresponds to 3.8 mg/L for both HepG2 after a 48-h incubation period and Caco2 after a 24-h incubation period, an acute cytotoxic effect is observed, and cell survival is below 20% compared to the control solution.…”
Section: Cytotoxicity Monitoringsupporting
confidence: 91%
See 1 more Smart Citation
“…For both HepG2 and Caco2, an approximately 20% decrease in cell survival after a 24 h incubation period is observed for an initial SER concentration of 6.25 µM. This agrees with data obtained previously for HepG2 cells treated with SER [48]. It was found that for SER concentrations above 12.5 µM, which corresponds to 3.8 mg/L for both HepG2 after a 48-h incubation period and Caco2 after a 24-h incubation period, an acute cytotoxic effect is observed, and cell survival is below 20% compared to the control solution.…”
Section: Cytotoxicity Monitoringsupporting
confidence: 91%
“…At a concentration of 7.5 µM sertraline, cell viability was reduced to approximately 83% compared to the DMSO control. Moreover, HepG2 viability detected by MTS decreased to about 23% when cells were treated with 15 µM sertraline, indicating that there was significant inhibition of growth and cell damage [48]. In the case of MCF-7 breast cancer cells, a much stronger effect was observed for sertraline, where the IC50 was approx.…”
Section: Cytotoxicity Monitoringmentioning
confidence: 96%
“…Numerous genomic and pharmacogenetic factors have been proved to influence the metabolism of psychotropic drugs, which might subsequently affect the efficacy and side effects. Some studies confirmed that CYP2D6, 2C19, 2B6, and 2C9-mediated metabolism is responsible for the metabolism of sertraline and the metabolism mediated by these CYPs rescued the cytotoxicity of sertraline (Chen et al, 2020). It has been reported that the genetic polymorphisms in CYP2C19 may influence metabolism of the escitalopram and treatment response (Tsai et al, 2010).…”
Section: Discussionmentioning
confidence: 95%
“…2,3 Significant effects of CYP2C19 variants on sertraline metabolism have already been observed by several studies, whereas there are no studies of CYP2B6 and sertraline in a large patient population. [2][3][4][5][6] By contrast, CYP2D6 and CYP2C9 variants are not predictors of sertraline metabolism, as shown by Braten et al 5 Regarding CYP3A4, a study with grapefruit juice, 7 which is a potent inhibitor, reported a 1.5-fold increase in sertraline exposure during juice consumption, suggesting a relevant impact of CYP3A4 on sertraline metabolism alongside CYP2C19 and CYP2B6. 7 CYP2C19 and CYP2B6 are highly polymorphic which influences the metabolism of clinically relevant drugs.…”
Section: Introductionmentioning
confidence: 97%